Update on the therapeutic approaches to brain tumors

Area of Science:

• Neuro-oncology
• Molecular Biology
• Genetics

Background:

• Neuro-oncology is rapidly advancing due to molecular biology and genetics.
• Improved diagnostic accuracy, safer surgical interventions, and more focused radiotherapy enhance patient care.
• Despite progress, prolonged survival remains a challenge for many brain tumor patients.

Purpose of the Study:

• To review standard and emerging therapies for gliomas and meningiomas.
• To discuss primary CNS lymphoma as a case study in neuro-oncology treatment evolution.

Main Methods:

• Literature review of standard and novel neuro-oncology treatments.
• Focus on therapeutic strategies informed by brain tumor biology.

Main Results:

• Significant advancements in diagnosis and treatment modalities for brain tumors.
• Emerging targeted therapies show promise but have limited impact on overall survival for many subsets.
• Primary CNS lymphoma treatment successes highlight neuro-oncology's evolution.

Conclusions:

• Continued research into targeted therapies is crucial for improving brain tumor patient outcomes.
• Understanding tumor biology is key to developing more effective treatments.
• Advances in neuro-oncology offer hope, but further progress is needed for widespread survival benefits.